Browse

ABSENCE OF SYMPTOM AND INTACT LIVER FUNCTION ARE POSITIVE PROGNOSTICATORS FOR PATIENTS UNDERGOING RADIOTHERAPY FOR LYMPH NODE METASTASIS FROM HEPATOCELLULAR CARCINOMA

Cited 14 time in Web of Science Cited 13 time in Scopus
Authors
Kim, Kyubo; Chie, Eui Kyu; Kim, Won; Kim, Yoon Jun; Lee, Hyo-Suk; Ha, Sung W.; Yoon, Jung Hwan
Issue Date
2010-11-01
Publisher
ELSEVIER SCIENCE INC
Citation
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS; Vol.78 3; 729-734
Keywords
Lymph node metastasisLiver functionHepatocellular carcinomaRadiotherapySymptoms
Abstract
Purpose: The positive role of radiotherapy for patients with lymph node (LN) metastasis from hepatocellular carcinoma has recently been reported. The outcome and prognostic factors for these patients were analyzed. Methods and Materials: Between May 2004 and October 2007,38 patients with LN metastases from hepatocellular carcinoma underwent radiotherapy. The median age was 59 years (range, 42-81). The radiation dose was 35-56 Gy with a fraction size of 1.8-3 Gy, for a biologically effective dose of 43.75-67.2 Gy(10) (median, 59.0). The median follow-up period was 8 months. Results: The median survival time was 10 months. On univariate analysis, Child-Pugh class B (p = .0006), distant metastasis (p = .0095), symptoms related to metastatic LNs (p <.0001), and a biologically effective dose <60 Gy(10) (p = .0042) were significant prognostic factors predicting for poor overall survival. On multivariate analysis after adjustment using the Benjamini and Hochberg (false discovery rate) method, Child-Pugh class B (p = .04095) and the presence of symptoms (p = .04095) were associated with inferior overall survival. When patients were divided into three groups according to these two risk factors, the median survival for patients with no, either, or both risk factors was 20, 7, and 4 months, respectively (p <.0001). Conclusion: Patients with intact liver function and without related symptoms had the best prognosis when undergoing radiotherapy for LN metastasis from hepatocellular carcinoma. (C) 2010 Elsevier Inc.
ISSN
0360-3016
Language
English
URI
http://hdl.handle.net/10371/77657
DOI
https://doi.org/10.1016/j.ijrobp.2009.08.047
Files in This Item:
There are no files associated with this item.
Appears in Collections:
College of Medicine/School of Medicine (의과대학/대학원)Internal Medicine (내과학전공)Journal Papers (저널논문_내과학전공)
  • mendeley

Items in S-Space are protected by copyright, with all rights reserved, unless otherwise indicated.

Browse